Bioprocess

Global Single-use Bioprocessing Market Outlook 2021-2026: Increasing Strategic Acquisitions & Partnerships, New Product Launches, & Technological Advances in SUB

Friday, April 9, 2021 - 2:30pm

DUBLIN, April 9, 2021 /PRNewswire/ -- The "Single-use Bioprocessing Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 9, 2021 /PRNewswire/ -- The "Single-use Bioprocessing Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026.
  • Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth.
  • The global single-use bioprocessing market research report includes a detailed segmentation by product, application, end-user, method, geography.

Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021

Tuesday, April 6, 2021 - 5:29am

Singapore, Apr 6, 2021 - (ACN Newswire) - Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, was named Best Bioprocessing Supplier in Single-Use Manufacturing at the Asia-Pacific Bioprocessing Excellence Awards 2021 held recently.

Key Points: 
  • Singapore, Apr 6, 2021 - (ACN Newswire) - Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, was named Best Bioprocessing Supplier in Single-Use Manufacturing at the Asia-Pacific Bioprocessing Excellence Awards 2021 held recently.
  • Avantor was also awarded Best Company in Bioprocessing Excellence for Single-use Solutions at Biologics Manufacturing Korea 2020.
  • For information, visit avantorsciences.com and find us on:
    The Asia-Pacific Bioprocessing Excellence Awards seeks to give recognition to exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence with enhanced speed, reduced cost, and superior quality.
  • 2021 marks the fifth year of ABEA, which was first established in 2017 and backed by industry requests.

Resolutions of the Annual Shareholders' Meeting of Sartorius AG

Friday, March 26, 2021 - 3:47pm

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry.

Key Points: 
  • The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry.
  • The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.
  • The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions complementary technologies.
  • At the end of 2020, nearly 11,000 people were employed at the Group's approximately 60manufacturing and sales sites, serving customers around the globe.

Global Single-use Bioprocessing Market (2021 to 2026) - High Utilization of Single-Use Bioprocessing For COVID-19 Vaccine Production Presents Opportunities - ResearchAndMarkets.com

Wednesday, March 24, 2021 - 4:51pm

The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026.

Key Points: 
  • The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during the period 2021-2026.
  • Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth.
  • The following factors are likely to contribute to the growth of the single-use bioprocessing market during the forecast period:
    The study considers the global single-use bioprocessing market's present scenario and its market dynamics for the period 2020-2026.
  • The global single-use bioprocessing market research report includes a detailed segmentation by product, application, end-user, method, geography.

Single-Use Bioprocessing Market Size to Reach Revenues of over USD 12 Billion by 2026 - Arizton

Wednesday, March 17, 2021 - 4:00pm

The single-use bioprocessing market is expected to grow at a CAGR of approximately 17% during the period 20192025.

Key Points: 
  • The single-use bioprocessing market is expected to grow at a CAGR of approximately 17% during the period 20192025.
  • Mergers and acquisitions among market players will assist them in enhancing their product portfolio as well as expand their geographic reach.
  • The purification market segment is likely to grow at a faster rate due to the growing usage of SUB in downstream bioprocessing.
  • Biopharmaceutical manufacturers occupy a significant share of the market, with single-use systems witnessing adoption in pre-commercial production processes.

Single-Use Bioprocessing Market Size to Reach Revenues of over USD 12 Billion by 2026 - Arizton

Wednesday, March 17, 2021 - 4:00pm

The single-use bioprocessing market is expected to grow at a CAGR of approximately 17% during the period 20192025.

Key Points: 
  • The single-use bioprocessing market is expected to grow at a CAGR of approximately 17% during the period 20192025.
  • Mergers and acquisitions among market players will assist them in enhancing their product portfolio as well as expand their geographic reach.
  • The purification market segment is likely to grow at a faster rate due to the growing usage of SUB in downstream bioprocessing.
  • Biopharmaceutical manufacturers occupy a significant share of the market, with single-use systems witnessing adoption in pre-commercial production processes.

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

Wednesday, March 17, 2021 - 11:30am

WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 23-24.

Key Points: 
  • WALTHAM, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the KeyBanc Life Science and MedTech Investor Forum being held March 23-24.
  • Tony Hunt, President & Chief Executive Officer, will participate in a fireside chat on Wednesday, March 24, at 9:15 a.m. EDT.
  • Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs.
  • Our corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide.

Sensorion to Present at Two Conferences on March 16th 2021

Friday, March 12, 2021 - 7:30am

CEO Nawal Ouzren will present an overview of Sensorions strategy in a virtual CEO Roundtable event at the WuXi Healthcare Forum 2021 , an investor and partnering meeting.

Key Points: 
  • CEO Nawal Ouzren will present an overview of Sensorions strategy in a virtual CEO Roundtable event at the WuXi Healthcare Forum 2021 , an investor and partnering meeting.
  • The presentation will be followed by an open Q&A session.
  • Sensorions Head of CMC Gene Therapy, Christine Le Bec, will speak in the Gene Therapy Analytics and Manufacturing session at the 4thAnnual Bioprocessing Summit Europe, held virtually.
  • Sensorion is a pioneering clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders.

RoosterBio Inc. Announces Winners of 2020 hMSC Development Grants

Thursday, March 11, 2021 - 2:00pm

FREDERICK, Md., March 11, 2021 /PRNewswire-PRWeb/ -- RoosterBio, a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, announced the 2020 Winners of our RoosterBio Development Award.

Key Points: 
  • FREDERICK, Md., March 11, 2021 /PRNewswire-PRWeb/ -- RoosterBio, a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, announced the 2020 Winners of our RoosterBio Development Award.
  • Each awardee will receive up to $12,000 in requested RoosterBio's hMSC and bioprocess media products in support of their respective proposed projects.
  • These systems have built-in design to streamline not just product development, but also to accelerate manufacturing processes for projects en route to early-stage clinical development.
  • RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers.

Advances in Bioprocess Technology Market to Pivot Biological Product Development, Therapeutics Based on Recombinant Proteins Attract Investments: TMR

Tuesday, March 9, 2021 - 3:30pm

The strides in the bioprocess technology have been viewed by numerous countries to increase their competitiveness in the biopharmaceutical sector.

Key Points: 
  • The strides in the bioprocess technology have been viewed by numerous countries to increase their competitiveness in the biopharmaceutical sector.
  • Rapid advances have been made in consumables and accessories, paving way to the commercialization of numerous biotech-derived products, including biologics.
  • Growing number of modified therapeutic proteins is a key trend shaping the bioprocess technology market landscape in developed regions of the world, such as in North America and Europe.
  • Growing development of recombinant therapeutic proteins for cancers, immune disorders, and infections is a key aspect for the expansion of research avenues in the market.